InforCapital
News

BC Partners raises €1.8bn, pushing toward a €5–6bn flagship plan.

BC Partners nets €1.8bn for new flagship fund, targeting €5–6bn with a potential €2bn first close by end-2025 amid fundraising headwinds. UK

AM
Alvaro de la Maza

Partner at Aninver

Key Takeaways

  • Geography: United Kingdom.

Analysis

According to sources, BC Partners has secured €1.8bn in commitments for its next flagship private equity vehicle and is moving toward a potential first close that market participants say could rise to €2bn by end-2025. The London-headquartered firm is aiming materially higher, targeting a fund size of between €5bn and €6bn.

The raise comes against a tougher backdrop for buyout fundraising. With portfolio companies taking longer to exit and capital recycling slowed, fundraisers across Europe are seeing more measured commitments from limited partners. Still, BC Partnerswhich manages roughly €40bn of assets—has leaned on recent exit momentum to underpin investor appetite.

Over the past two years the firm has returned approximately €17bn to its backers, fuelled by a string of strategic sales. Notable transactions highlighted by sources include the disposal of its majority stake in Dutch generics maker Synthon to an alternatives arm of Goldman Sachs Asset Management, and the carve-out sale of its controlling interest in Canadian security services group GardaWorld. Those exits have helped sharpen BC Partners’ fundraising story.

On the active deal front the firm continues to support portfolio companies toward public markets. One high-profile example is UK specialty lender Shawbrook Group, which BC Partners is preparing for a London initial public offering that could value the business at up to £2bn (around $2.7bn).

For BC Partners, a successful close at or near the €5–6bn ambition would cement its place among Europe’s larger buyout managers and provide firepower for mid-to-large-cap transactions across healthcare, services and industrials — sectors where the firm has a long track record. Conversely, an extended capital raise could expose the firm to pricing competition if deal flow re-accelerates while the fund remains under-committed.